AETHLON MEDICAL financials
$6.380.00%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 | FY21 Mar 31 | FY20 Mar 31 | FY19 Mar 31 | FY18 Mar 31 | FY17 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K |
| Gross profit | $0.00 | $0.00 | $0.00 | $574.2K | $294.2K | $659.1K | $650.2K | $229.6K | $149.6K | $392.1K |
| Gross margin | — | — | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$7.3M | -$9.3M | -$12.6M | -$11.9M | -$10.4M | -$7.9M | -$5.9M | -$6.0M | -$4.8M | -$6.1M |
| Net income | -$7.2M | -$13.4M | -$12.2M | -$12.0M | -$10.4M | -$7.9M | -$6.4M | -$6.2M | -$1.3M | -$7.3M |
| Net margin | — | — | — | −2094.9% | −3540.9% | −1196.6% | −980.3% | −2697.8% | −842.6% | −1855.8% |
| Diluted EPS | $-53.05 | $-428.85 | $-1943.50 | $-2344.00 | $-2840.00 | $-2600.00 | $-7480.00 | $-20520.00 | $-6000.00 | $-56400.00 |
| EBITDA | -$7.0M | -$9.0M | -$12.3M | -$11.7M | -$10.3M | -$7.9M | -$5.9M | -$6.0M | -$4.8M | -$6.1M |
| Operating cash flow | -$7.0M | -$7.6M | -$10.1M | -$10.5M | -$9.8M | -$6.8M | -$5.2M | -$4.3M | -$3.9M | -$3.5M |
| Free cash flow | -$7.0M | -$7.6M | -$10.4M | -$11.4M | -$10.1M | -$6.8M | -$5.3M | -$4.3M | -$3.9M | -$3.5M |
| Diluted shares | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.0M | $5.5M | $5.4M | $14.5M | $17.1M | $9.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $6.3M | $7.4M | $8.2M | $17.5M | $19.4M | $10.7M |
| Total liabilities | $1.4M | $2.2M | $2.5M | $2.4M | $2.4M | $1.4M |
| Shareholders' equity | $4.9M | $5.1M | $5.8M | $15.1M | $17.0M | $9.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology